168 related articles for article (PubMed ID: 36200043)
1. An
Wang CD; Xu S; Chen S; Chen ZH; Dean N; Wang N; Gao XD
Front Cell Dev Biol; 2022; 10():1008078. PubMed ID: 36200043
[TBL] [Abstract][Full Text] [Related]
2. Alg14 recruits Alg13 to the cytoplasmic face of the endoplasmic reticulum to form a novel bipartite UDP-N-acetylglucosamine transferase required for the second step of N-linked glycosylation.
Gao XD; Tachikawa H; Sato T; Jigami Y; Dean N
J Biol Chem; 2005 Oct; 280(43):36254-62. PubMed ID: 16100110
[TBL] [Abstract][Full Text] [Related]
3. Interaction between the C termini of Alg13 and Alg14 mediates formation of the active UDP-N-acetylglucosamine transferase complex.
Gao XD; Moriyama S; Miura N; Dean N; Nishimura S
J Biol Chem; 2008 Nov; 283(47):32534-41. PubMed ID: 18809682
[TBL] [Abstract][Full Text] [Related]
4. Alg14 organizes the formation of a multiglycosyltransferase complex involved in initiation of lipid-linked oligosaccharide biosynthesis.
Lu J; Takahashi T; Ohoka A; Nakajima K; Hashimoto R; Miura N; Tachikawa H; Gao XD
Glycobiology; 2012 Apr; 22(4):504-16. PubMed ID: 22061998
[TBL] [Abstract][Full Text] [Related]
5. Membrane topology of the Alg14 endoplasmic reticulum UDP-GlcNAc transferase subunit.
Averbeck N; Keppler-Ross S; Dean N
J Biol Chem; 2007 Oct; 282(40):29081-8. PubMed ID: 17686769
[TBL] [Abstract][Full Text] [Related]
6. Structural Analysis of the Effect of Asn107Ser Mutation on Alg13 Activity and Alg13-Alg14 Complex Formation and Expanding the Phenotypic Variability of ALG13-CDG.
Mitusińska K; Góra A; Bogdańska A; Rożdżyńska-Świątkowska A; Tylki-Szymańska A; Jezela-Stanek A
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327592
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis of lipid-linked oligosaccharides in Saccharomyces cerevisiae: Alg13p and Alg14p form a complex required for the formation of GlcNAc(2)-PP-dolichol.
Bickel T; Lehle L; Schwarz M; Aebi M; Jakob CA
J Biol Chem; 2005 Oct; 280(41):34500-6. PubMed ID: 16100113
[TBL] [Abstract][Full Text] [Related]
8. Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: Clinical description, biomarker status, biochemical analysis, and treatment suggestions.
Ng BG; Eklund EA; Shiryaev SA; Dong YY; Abbott MA; Asteggiano C; Bamshad MJ; Barr E; Bernstein JA; Chelakkadan S; Christodoulou J; Chung WK; Ciliberto MA; Cousin J; Gardiner F; Ghosh S; Graf WD; Grunewald S; Hammond K; Hauser NS; Hoganson GE; Houck KM; Kohler JN; Morava E; Larson AA; Liu P; Madathil S; McCormack C; Meeks NJL; Miller R; Monaghan KG; Nickerson DA; Palculict TB; Papazoglu GM; Pletcher BA; Scheffer IE; Schenone AB; Schnur RE; Si Y; Rowe LJ; Serrano Russi AH; Russo RS; Thabet F; Tuite A; Villanueva MM; Wang RY; Webster RI; Wilson D; Zalan A; ; Wolfe LA; Rosenfeld JA; Rhodes L; Freeze HH
J Inherit Metab Dis; 2020 Nov; 43(6):1333-1348. PubMed ID: 32681751
[TBL] [Abstract][Full Text] [Related]
9. ALG13 X-linked intellectual disability: New variants, glycosylation analysis, and expanded phenotypes.
Alsharhan H; He M; Edmondson AC; Daniel EJP; Chen J; Donald T; Bakhtiari S; Amor DJ; Jones EA; Vassallo G; Vincent M; Cogné B; Deb W; Werners AH; Jin SC; Bilguvar K; Christodoulou J; Webster RI; Yearwood KR; Ng BG; Freeze HH; Kruer MC; Li D; Raymond KM; Bhoj EJ; Sobering AK
J Inherit Metab Dis; 2021 Jul; 44(4):1001-1012. PubMed ID: 33734437
[TBL] [Abstract][Full Text] [Related]
10. ALG13-Congenital Disorder of Glycosylation (ALG13-CDG): Updated clinical and molecular review and clinical management guidelines.
Shah R; Eklund EA; Radenkovic S; Sadek M; Shammas I; Verberkmoes S; Ng BG; Freeze HH; Edmondson AC; He M; Kozicz T; Altassan R; Morava E
Mol Genet Metab; 2024 Jun; 142(2):108472. PubMed ID: 38703411
[TBL] [Abstract][Full Text] [Related]
11. Solution structure of Alg13: the sugar donor subunit of a yeast N-acetylglucosamine transferase.
Wang X; Weldeghiorghis T; Zhang G; Imperiali B; Prestegard JH
Structure; 2008 Jun; 16(6):965-75. PubMed ID: 18547528
[TBL] [Abstract][Full Text] [Related]
12. Hetero-oligomeric interactions between early glycosyltransferases of the dolichol cycle.
Noffz C; Keppler-Ross S; Dean N
Glycobiology; 2009 May; 19(5):472-8. PubMed ID: 19129246
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes in ALG13-Congenital Disorder of Glycosylation.
Shah R; Johnsen C; Pletcher BA; Edmondson AC; Kozicz T; Morava E
Am J Med Genet A; 2023 Jun; 191(6):1626-1631. PubMed ID: 36930724
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of UDP-GlcNAc:Dolichol Phosphate N-Acetylglucosamine-1 Phosphate Transferase (DPAGT1) causes a novel congenital disorder of Glycosylation Type Ij.
Wu X; Rush JS; Karaoglu D; Krasnewich D; Lubinsky MS; Waechter CJ; Gilmore R; Freeze HH
Hum Mutat; 2003 Aug; 22(2):144-50. PubMed ID: 12872255
[TBL] [Abstract][Full Text] [Related]
15. ALG1-CDG: a new case with early fatal outcome.
Rohlfing AK; Rust S; Reunert J; Tirre M; Du Chesne I; Wemhoff S; Meinhardt F; Hartmann H; Das AM; Marquardt T
Gene; 2014 Jan; 534(2):345-51. PubMed ID: 24157261
[TBL] [Abstract][Full Text] [Related]
16. Exome sequence identified a c.320A > G ALG13 variant in a female with infantile epileptic encephalopathy with normal glycosylation and random X inactivation: Review of the literature.
Hamici S; Bastaki F; Khalifa M
Eur J Med Genet; 2017 Oct; 60(10):541-547. PubMed ID: 28778787
[TBL] [Abstract][Full Text] [Related]
17. The First Metabolome Analysis in Children with Epilepsy and ALG13-CDG Resulting from c.320A>G Variant.
Paprocka J; Jezela-Stanek A; Boguszewicz Ł; Sokół M; Lipiński P; Jamroz E; Emich-Widera E; Tylki-Szymańska A
Children (Basel); 2021 Mar; 8(3):. PubMed ID: 33807002
[TBL] [Abstract][Full Text] [Related]
18. Guanosine diphosphate-mannose:GlcNAc2-PP-dolichol mannosyltransferase deficiency (congenital disorders of glycosylation type Ik): five new patients and seven novel mutations.
Dupré T; Vuillaumier-Barrot S; Chantret I; Sadou Yayé H; Le Bizec C; Afenjar A; Altuzarra C; Barnérias C; Burglen L; de Lonlay P; Feillet F; Napuri S; Seta N; Moore SE
J Med Genet; 2010 Nov; 47(11):729-35. PubMed ID: 20679665
[TBL] [Abstract][Full Text] [Related]
19. [New variant in the ALG13 gene responsible for the congenital disorder of Is-type glycosylation in a male patient].
Ramírez-Montaño D; Candelo E; Pachajoa H
Andes Pediatr; 2021 Oct; 92(5):769-776. PubMed ID: 35319586
[TBL] [Abstract][Full Text] [Related]
20. ALG13-CDG with Infantile Spasms in a Male Patient Due to a De Novo ALG13 Gene Mutation.
Galama WH; Verhaagen-van den Akker SLJ; Lefeber DJ; Feenstra I; Verrips A
JIMD Rep; 2018; 40():11-16. PubMed ID: 28887793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
